lord-ashcroft’s-new-book,-“red-knight:-the-unauthorised-biography-of-sir-keir-starmer”,-is-published-today

Lord Ashcroft’s new book, “Red Knight: The Unauthorised Biography of Sir Keir Starmer”, is published today

 

Sir Keir Starmer has played many parts during his life and career. He went from schoolboy socialist to radical lawyer before surprising many by joining the establishment, becoming Director of Public Prosecutions, accepting a knighthood and then, in 2015, standing successfully for Parliament. At Westminster, he was swiftly elevated to the shadow Cabinet, and in April 2020 he became the leader of the Labour Party.

Michael Ashcroft’s new book goes in search of the man who wants to be Prime Minister and reveals previously unknown details about him which help to explain what makes him tick.

Starmer was the architect of Labour’s second-referendum Brexit policy, which was considered a major factor in its worst electoral defeat for nearly a century. Is he the man to bring back Labour’s lost voters? Is he the voice of competence and moderation who can put his party back on the political map? Or is he just a member of the metropolitan elite who is prepared to say and do whatever it takes to win favour?

This meticulous examination of his life offers voters the chance to answer these vital questions.

scibase-nominating-committee-proposes-the-election-of-dr-jvalini-dwarkasing-as-a-new-board-member

SciBase nominating committee proposes the election of Dr Jvalini Dwarkasing as a new Board member

 

SciBase Holding AB (“SciBase”) (STO:SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today that the Nominating Committee proposes the election of Dr. Jvalini Dwarkasing as a new Board member at an extraordinary general meeting to be proposed by the Board of Directors of SciBase.

The nominating committee, consisting of Christer Jönsson (appointed by FourierTransorm), Iraj Arastoupour, Peter Elmvik and Tord Lendau Chairman of the Board, hereby proposes the election of Dr. Jvalini Dwarkasing as a new member of the Board to an EGM to be held later in 2021.

Dr Dwarkasing, proposed to the nominating committee by Van Herk Investments, is currently the Chief Scientific Officer at SkylineDx. She has over 10 years of life science experience with an international track record within oncology having held both research and management positions. Dr Dwarkasing has a strong academic background and a PhD in medical nutrition and pharmacology. Her driver for doing research is patient focus and how to bring science from bench to bedside. Her geographical areas of focus are the US, Europe and Australia.

The nominating committee believes that her knowledge and experience within the fields of Dermatology/Pathology, the international Dermatology industry and Dermatology networks are aligned with the future competence needs for the SciBase Board of Directors.

cloopen-group-holding-limited-(nyse:-raas)-announces-financial-results-for-second-quarter-2021

Cloopen Group Holding Limited (NYSE: RAAS) Announces Financial Results for Second Quarter 2021

 

 

The thriving stay-at-home economy that emerged in 2020 unleashed the potential of the cloud-based communications market. Rising alongside the ongoing improvement of the communications infrastructure, the market is entering a golden age. The cloud-based communications market in China will continue to grow rapidly in the coming years and is expected to exceed RMB100 billion by 2024, according to a report from China Investment Corporation (CIC).

With the sector’s anticipated growth, industry players are fulfilling expectations by continually delivering notable performances. Recently, Cloopen Group Holding Limited (NYSE: RAAS) (“Cloopen” or the “Company”) announced its financial results for the second quarter of 2021. According to the report, the Company’s revenues for the second quarter were RMB274 million, representing a 47.9% increase year-over-year or a 33.9% increase quarter-over-quarter. Its core CC (Cloud-based Contact Center) solutions business performed especially well, achieving revenues of RMB108 million, an increase of 105.1% year-over-year. In terms of profitability, the Company’s gross margin increased to 43.1%. Adjusted EBITDA loss was RMB29.966 million, while adjusted EBITDA loss margin (as a percentage of revenue) decreased markedly to 10.9%, a nearly 6% decrease year-over-year and an 18% decrease quarter-over-quarter.

Three-month Period Ended, 

June 30, 

June 30, 

June 30, 

2020

2021

2021

RMB 

RMB 

USD 

(in thousands, except for per share data) 

Revenues

185,255

273,905

42,422

Cost of revenues

(113,856)

(155,805)

(24,131)

Gross profit 

71,399

118,100

18,291

Operating expenses: 

Research and development expenses

(36,644)

(61,970)

(9,598)

Sales and marketing expenses

(46,643)

(72,842)

(11,282)

General and administrative expenses

(46,240)

(79,664)

(12,338)

Total operating expenses 

(129,527)

(214,476)

(33,218)

Operating loss 

(58,128)

(96,376)

(14,927)

Other income (expense):

Interest expenses

(4,141)

(119)

(18)

Interest income

479

1,265

196

Loss from disposal of subsidiaries, net

(335)

(4)

(1)

Share of income (loss) of equity method investments

(1,021)

8

1

Change in fair value of warrant liabilities

722

Impairment loss of long-term investments

(15,667)

(2,427)

Foreign currency exchange gains (losses), net

(270)

4,028

624

Loss before income taxes 

(62,694)

(106,865)

(16,552)

Income tax benefit

529

1,232

191

Net loss 

(62,165)

(105,633)

(16,361)

Cloopen optimized revenue structure by increasing proportion of businesses with higher gross margins

Cloopen, began to provide cloud-based communications solutions in 2014, went public in the US in February of this year, becoming the first Chinese SaaS company to do so. After over a decade of development, the Company’s businesses now include communications platform as a service (CPaaS),Cloud-based Contact center (CC) and Cloud-based Unified Communications and Collaboration(UC&C).

In terms of revenue composition, CPaaS revenue reached RMB115 million in the second quarter,maintaining organic growth rate of 13% year-over-year. The high-margin CC and UC businesses contributed more than 50% of total revenue for the first time, and CC solutions contributed significantly to revenue growth. In recent years, the CC solutions market has maintained rapid growth, attracting the attention of the industry’s powerful players.

Against the backdrop of a thriving market, Cloopen delivered positive news regarding its CC solutions business. During the reporting period, the Company’s CC business achieved revenues of RMB108 million, an increase of over 100% year-over-year.

Two factors account for the exceptional performance of the CC business. First, Cloopen’s acquisition of CRM software provider EliteCRM in March of this year and its integration enabled strategic synergies. Second, the Company expanded its CC business by adding CRM and CPaaS products, producing a compound sales effect and further growing market share.

Another part of Cloopen’s revenue composition consists of UC&C solutions, which include IM and CV services. Compared to CPaaS and CC solutions, the UC&C solutions business is smaller in volume, having achieved revenues of RMB49 million in the second quarter, an impressive increase of 74.9%.

In addition to strong revenues, Cloopen’s performance showed laudable profitability. The financial report revealed the Company’s gross margin to be 43.1%, compared to 38.5% in the second quarter of 2020. Cloopen’s improved profitability was primarily driven by an increase in the proportion of the Company’s higher gross margin businesses. According to previous financial reports, the gross margins of Cloopen’s CC and UC&C businesses are considerably higher than that of its CPaaS business. In the second quarter of this year, the proportion of the Company’s higher gross margin businesses surpassed 50% for the first time, boosting the overall gross margin while significantly optimizing the Company’s revenue structure. Meanwhile, the Company’s reduced the red ink considerably, with an adjusted EBITDA loss of RMB29.966 million.

According to Chinese information platform Zhitong Caijing, Cloopen’s second quarter financial report showed overall positive results in its core financial data, once again demonstrating indications of growth.

Potential for growth in the industry

Cloopen is situated within a thriving industry. As aforementioned, the cloud-based communications industry is expected to become a RMB100 billion market in the near future. The CIC report indicated that the cloud-based communication solutions market increased from RMB16.3 billion in 2015 to RMB35.7 billion in 2019, representing a compound annual growth rate of 21.7%.

The market is expected to maintain strong growth momentum. CIC forecasted that the market is expected to reach RMB100 billion by 2024, with a compound annual growth rate of 23.3% during the 2019 to 2024 period.

Cloopen has the potential for greater growth in this market. The cloud-based communications market consists of three major segments: CPaaS, CC and UC&C. Cloopen boasts a comprehensive product portfolio that covers the three major segments CPaaS, CC and UC&C, enabling the Company to accommodate a multitude of business scenarios and provide customers with versatile solutions.

Cloopen also has a competitive edge due to its technology and customer base. First let’s consider technological advantages and look at Cloopen’s newest product developments as an example. At the World Artificial Intelligence Conference in June 2021 (WAIC 2021), Cloopen debuted Rongxi Robot, which features intelligent voice response systems and outbound solutions, intelligent training capabilities, and AI-assisted customer support. By combining the technologies operating at every level – algorithms at the bottom, AI data in the middle, and AI applications at the top, the Company delivered a comprehensive upgrade of CC solutions that can be applied to the full customer lifecycle.

Next let’s examine Cloopen’s customer base. According to the financial report, the Company had 12,976 active customers as of the end of June this year, with a dollar-based net customer retention rate of around 110%. A large customer base combined with a high retention rate helps provide the Company’s with stable revenues.

Aside from its strong performance, the outlook for the Company’s future development is also promising. In terms of its industry, Cloopen conducts business in a fast-growing industry that has entered a golden age. In terms of its performance, there has been continual evidence of the Company’s growth. One can expect Cloopen to further unlock its growth potential, owing to its dominant position in product offerings, research and development, and customer base.

SOURCE Cloopen

scibase:-interim-report

SciBase: Interim report

 

The second quarter in figures

  • Net sales amounted to TSEK 2,258 (1,683).
  • The loss after tax amounted to TSEK 11,151 (8,864).
  • The loss per share amounted to SEK 0.19 (0.38).
  • The cash flow from current operations was negative in the amount of TSEK 9,162 (8,704).
  • The gross margin reached 56.3% (55.7%).
  • Electrode sales volume increased by 28% and reached 5,968 (4,672) units. Repeat sales of electrodes to existing customers increased by 23%.

January – June in figures

  • Net sales amounted to TSEK 4,821 (4,179).
  • The loss after tax amounted to TSEK 19,304 (17,800).
  • The loss per share amounted to SEK 0.34 (0.89).
  • The cash flow from current operations was negative in the amount of TSEK 18,635 (16,597).
  • The gross margin reached 54.4% (54.7%).
  • Electrode sales volume increased by 19% and reached 13,464 (11,270) units. Repeat sales of electrodes to existing customers increased by 20%.

Important events during the quarter

  • Overall sales increased by 34% (cleared for currency effects +43%). Covid-19 continues to affect sales and the market situation remains difficult to predict going forward, due to ongoing lockdowns and reduced marketing activities. Sales in the company’s key market Germany increased by 13% (cleared for currency effects +19%).
  • SciBase performed two successful directed share issues which raised approximately MSEK 66.5 net, after issue costs.
  • SciBase submitted the first US reimbursement application to CMS’s Medicare Contractor in Florida, First Coast Service Options (FCSO). The application for Medicare coverage in Florida marks an important step in the reimbursement process for SciBase and is a necessary step towards broader penetration and usage of the Nevisense test.
  • SciBase received certification under the new Medical Device Regulation (MDR).
  • The new Non-Melanoma Skin Cancer (NMSC) clinical application was launched following the completion of the MDR certification process.
  • A groundbreaking article by key SciBase collaborator Professor Cezmi Akdis presenting the “epithelial barrier hypothesis” was published in Nature Reviews Immunology. The article presented the background for the steep increase in allergic and other diseases over the last decades, and how this increase is connected to degradation in barrier function in the body.
  • A new clinical study from the Swiss Institute of Allergy and Asthma Research (SIAF) was published in the European Journal of Allergy and Clinical Immunology (Allergy). In the study Nevisense was used to assess the skin barrier of patients with atopic dermatitis (AD) and could accurately detect signs of barrier degradation in atopic patients, even in visually unaffected skin. Nevisense measurements also correlated with relevant biomarkers for atopic dermatitis.
  • The notice to attend the AGM 2021 was published as well as the nominating committees supplementary proposal to nominate Dr Matt Leavitt for the Board of Directors.
  • The AGM 2021 was held on May 18.
  • An EGM was held on June 16th.
  • The annual report 2020 was published on April 9th.

Important events after the end of the  period

  • SciBase has entered into an agreement with Vator Securities AB (“Vator Securities“) regarding the service as a Certified Adviser. Vator Securities will take over as Certified Adviser on September 28, 2021. Until Vator Securities takes over, Avanza Bank AB will continue to act as Certified Adviser for the Company.

Apr 1 – June 30

Jan 1 – June 30

July 1 2020 –
June 30 2021

Jan 1 – Dec 31

THE GROUP

2021

2020

2021

2020

Rolling-12

2020

Net sales, SEK ths

2 258

1 683

4 821

4 179

10 163

9 521

Gross margin, %

56,3%

55,7%

54,4%

54,7%

52,5%

52,5%

Equity/Asset ratio, %

87,3%

69,2%

87,3%

69,2%

81,7%

79,1%

Net indebtness, multiple

0,15

0,44

0,15

0,44

0,22

0,26

Cash equivalents, SEK ths

88 192

30 450

88 192

30 450

88 192

41 427

Cashflow from operating activities, SEK ths

-9 162

-8 704

-18 635

-16 597

-35 899

-33 861

Earnings per share (before and after dilution), SEK

-0,19

-0,38

-0,34

-0,89

-0,72

-1,12

Shareholder’s equity per share, SEK

1,59

1,44

1,65

1,68

1,25

1,50

Average number of shares, 000′

59 265

23 265

57 023

19 942

50 949

31 287

Number of shares at closing of period, 000′

68 236

36 560

68 236

36 560

68 236

54 780

Share price at end of period, SEK

5,52

2,44

5,52

2,44

5,52

4,62

Number of sold electrodes, pieces

5 968

4 672

13 464

11 270

27 880

25 686

Average number of employees

17

16

17

16

17

16


This information is information that SciBase Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 08.00 CET on August 19, 2021.

This information is information that SciBase Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 08.00 CET on August 19, 2021.

hyperlink-infosystem-announces-participation-in-gitex-2021-one-of-the-biggest-it-trade-shows-in-middle-east

Hyperlink InfoSystem Announces Participation in GITEX 2021 One of The Biggest IT Trade Shows in Middle East

 

GITEX Technology Week 2021, the biggest technology event will take place in Dubai between 17th October to 21st October, 2021. GITEX is one of the biggest shows in the annual tech calendar, with over 4,500 exhibitors from around the globe, with over 1,00,000 visitors from the MEASA region and over 18,000 pre-rearranged meetings. Moreover, 800+ government entities from the MEASA region create the most significant public/private sector MOU signing platform. The international and local audience visit one event per year, and among them, they have selected GITEX as their primary platform to network and do business.

GITEX is hosted alongside the Dubai Expo for the biggest gathering of the tech community to transform the future of the digital economy. It is one of the undisputed tech event for the last 41 years, where global industry leaders, startups, and game-changers meet to uncover the top, as it happens. The latest in AI, 5G, Cloud, Big Data, Cybersecurity, Blockchain, Quantum Computing, Immersive Marketing, and Fintech–the only event to spotlight global tech visions at the international scale.

Hyperlink InfoSystem, a leading custom software development company, will exhibit again in GITEX technology week – #GITEX2021 and showcase the services and solutions using the latest technologies like AI, IoT, Blockchain, AR/VR, and Big Data for startups to enterprise-level businesses. Hyperlink InfoSystem is very well known for developing the best quality with the latest technology, which eases earning a large amount of profit for all types of businesses. After successfully participating in GITEX for many years, Hyperlink InfoSystem continues to showcase smart solutions worldwide by GITEX 2021.

The CEO of Hyperlink InfoSystem, Mr. Harnil Oza, says, “It is the fifth time we are going to exhibit our services at GITEX. We are happy to showcase our innovations, creativity and share knowledge in diverse areas, including mobility, web, IoT, Big Data, Salesforce, Cloud and AI. No matter how advanced they may be, technologies offer no value to us unless they can create experiences. And I, too, believe the same. Hyperlink InfoSystem has been creating experiences to help businesses increase their reach and thrive. Schedule a meeting with our team at GITEX and discuss the next-gen tech solution idea.”

If anyone has an innovative idea, Hyperlink InfoSystem can help them take the digital world by passion. They can directly interact with the Hyperlink InfoSystem’s team at GITEX 2021 at H7-11 at Dubai World Trade Center from 17th October to 21st October, 2021. One can also enquire at +18057441224 or email at [email protected]

new-2022-kia-sorento-phev-joins-popular-suv-model-range

NEW 2022 KIA SORENTO PHEV JOINS POPULAR SUV MODEL RANGE

 

The 2022 Sorento Turbo Plug-in Hybrid (PHEV) SUV is the latest addition to Kia’s ambitious ‘Plan S’ electrification strategy and the fourth generation Sorento model range, which was introduced last year in both gasoline-powered and turbo hybrid electric vehicle (HEV) forms.  Offering power, efficiency, all-wheel drive capability and three-row seating accommodations, the 2022 Sorento Turbo PHEV will arrive in showrooms in the third quarter of 2021. Pricing will be announced closer to its on-sale date.

The new Sorento PHEV is offered with a 66.9 kW electric motor and a 1.6-liter turbocharged engine that combine to achieve 261 horsepower.  The Sorento PHEV has a targeted 32-mile pure electric driving range, the best of any 3-row PHEV SUV,3 with a projected combined overall range of 460 miles, helping it achieve a targeted 79 MPGe combined rating.1 Enhancing Sorento’s capabilities is standard torque-vectoring all-wheel-drive, offering go-anywhere confidence.

The Sorento PHEV delivers an upscale and feature-rich cabin accommodating up to six passengers.  Its 143.8 cubic feet of passenger space and second-row legroom better any other PHEV SUV.2 Furthermore, it is the only mainstream PHEV SUV to offer three-row seating.

“The Sorento PHEV’s rare combination of drivability, efficiency and spaciousness will make it a compelling choice for our customers,” said Sean Yoon, president & CEO, Kia North America and Kia America. “We’re proud to have it join the popular Sorento model range while also playing a pivotal role in the launch of Kia’s Plan S electrification strategy.”

The 2022 Kia Sorento PHEV will be offered in two trims: SX and SX-P.  It will be built in Hwasung, Korea alongside the Sorento HEV.

A Modern Design

The exterior of the 2022 Sorento PHEV is defined by the same sharp, modern lines and high-tech details as the rest of the Sorento range.  PHEV-specific elements include:

  • Specialized rear badging
  • Plug port located at rear quarter panel
  • Standard 19-inch wheels

The Sorento PHEV offers 143.8 cubic feet of passenger space, the most of any PHEV SUV.2 It also has more second-row legroom than any PHEV SUV.2 In addition to its roominess, premium feel, and vast feature content, the Sorento PHEV’s interior offers the following highlights:

  • Standard three-row seating with second-row captain’s chairs
  • Standard Syntex synthetic leather seating or available perforated leather seats
  • Available aluminum sport pedals

A Strong Foundation

The 2022 Sorento PHEV is built on the strong and versatile “N3” platform.  Highlights include:

  • Wheelbase is increased by nearly 1.4 inches over the previous generation of Sorento for more interior space
  • Average tensile strength is improved by 4 percent compared to the previous generation of Sorento
  • Improved driving dynamics, ride and handling, and noise, vibration, and harshness (NVH)
  • Distribution of impact kinetic energy forces through multi-load-path body structure

PHEV Performance

A smooth and familiar driving experience for the 2022 Sorento PHEV comes from a sophisticated powertrain with a proven AWD system:

  • A turbocharged 1.6-liter GDI 4-cylinder engine with a 66.9 kW electric motor
    • 6-speed automatic transmission with standard paddle shifters
    • 261 horsepower combined
    • 8 kWh battery
    • Targeted 32-mile all-electric range1
    • Targeted 79 MPGe Combined rating1
    • Standard AWD with center locking differential and Drive Mode Select with Snow Mode5

On the Tech Side

Like the rest of the Sorento model range, the Sorento PHEV offers a wide array of available technology:

  • 3-in. full digital meter cluster, a first for any Kia SUV (SX-P)
  • Surround View Monitor utilizes four cameras to provide a 360-degree perspective around the vehicle, enhancing driver confidence in tight parking situations (SX-P)6
  • Blind View Monitor projects live video view of adjacent lanes in the instrument cluster and is activated via the turn signal (SX-P)6
  • Electrochromic rear view mirror (SX-P)
  • Smart key with pushbutton start and remote start (from key fob)7
  • 8 USB charging ports
  • 25-inch high-resolution color touchscreen display with navigation and telematics (UVO link)8
  • SiriusXM9 satellite radio
  • Wireless smartphone charging pad10
  • Bose11 premium sound system, available with 12 high-performance speakers
    • Bose Centerpoint technology converts stereo sources into a richer surround-sound experience
    • Dynamic Speed Compensation analyzes the sound source and automatically adjusts according to speed
  • Standard Rear Occupant Alert (ROA)12 uses ultrasonic sensors engineered to detect child or pet movement in the second and third rows after the doors have been locked and then can notify the driver and surrounding area by sounding the horn and illuminating the hazard lamps

A Connected Experience

UVO link8 telematics offers an array of advanced connected vehicle features, such as:

  • Connected Routing13: A new cloud-based route calculation system that uses UVO cloud to calculate the optimal route using real-time maps, predicted upcoming traffic info based on historical information and AI to learn the preferred routes of users
  • Connected Weather: Provides weather information for more than 25,000 cities
  • Enhanced UVO voice assist feature allows voice control of the vehicle’s climate, seat and steering-wheel heating, audio system, and other functions
  • Connected User Profiles: Allows customers to add an additional driver to their vehicle. The drivers can add their individual UVO accounts to the vehicle and have access to remote features using the Kia Access App. The profile stores some select settings on the UVO cloud and can be shared with other compatible Kia vehicles
  • UVO & Smart Speaker Integration lets customers use Amazon Alexa or Google Assistant enabled smart speakers or devices to remotely control some functions (such as remote start)14
  • Advanced notifications:
    • Engine Idle Notification and Automatic Engine Shut Off notifies the driver via the UVO link app if the engine is left idling and, after a pre-selected time, turns off the engine15
    • 911 Connect and Roadside Assistance will automatically attempt to call 911 via the built-in UVO modem if an airbag deploys. For non-emergencies, it can connect with 24/7 roadside assistance and share the vehicle’s location16
  • Also available within UVO, for the first time on any Kia, are two new features:
    • On-demand Find My Car with Surround View Monitor uses the vehicle cameras to capture images of the vehicle’s surroundings and then share them via the Kia Access app17
    • Last Mile Navigation provides walking directions to the driver’s final destination if the vehicle is parked between 0.1 and 1.2 miles away18

Advanced Driver-Assistance Systems

The Sorento PHEV offers a full suite of standard Kia Drive Wise Advanced Driver-Assistance Systems (ADAS)4:

  • Blind Spot Collision Avoidance Assist – Rear (BCA-Rear) with parallel exit: Under certain conditions, can detect vehicles traveling in the next lane. When a vehicle is “seen” in the blind spot, the vehicle brakes the outer wheel under certain conditions to help return the vehicle to its lane
  • Driver Attention Warning (DAW)19: Senses inattentive driving patterns and sends an audible/visual warning to alert the driver
  • Forward Collision Warning (FCW): Designed to detect a vehicle ahead in the lane and in certain conditions, calculates distance and closing speed to issue an alert to the driver if it senses a potential frontal collision
  • Forward Collision-Avoidance Assist (FCA): Builds on FCW by assisting the driver when braking to help prevent a collision or lessen the effects in certain conditions if a vehicle, pedestrian or cyclist is detected in front
  • Forward Collision Avoidance Assist (FCA) – Junction Turning (FCA-JT): Assists the driver in braking to help prevent a collision or lessen the effects in certain conditions when turning left and an oncoming vehicle is approaching
  • Highway Driving Assist (HDA)20: Uses federal highway speed limit information from the navigation system and, under certain conditions, will automatically adjust speed to be within the posted speed limit and maintain distance with the vehicle detected in front
  • Intelligent Speed Limit Assist (ISLA): Automatically changes set speed of Smart Cruise Control by using the speed limit information detected through the front camera or GPS navigation information (when activated)
  • Lane Following Assist (LFA): Follows lane markings that the system detects and provides steering inputs to help maintain the vehicle in the center of the lane
  • Navigation Based Smart Cruise Control-Curve (NSCC-C): Leverages the navigation system to lower the vehicle’s speed proactively before upcoming curves
  • Parking Distance Warning-Reverse (PDW-R): Detects certain objects behind the vehicle, issuing an audible warning when an obstruction is detected. The warning tone chimes faster as the vehicle gets closer to the detected object
  • Rear Cross-Traffic Collision Avoidance Assist (RCCA): Helps detect most approaching cross traffic when in reverse. When approaching cross traffic is detected, the system alerts the driver and may apply the brakes
  • Safe Exist Assist (SEA)21: Can alert the driver or passengers opening their door not to exit the vehicle when the system detects approaching traffic. When detected, a chime sounds. The system can intervene to lock the rear doors when the vehicle is equipped with available Power Child Lock

Kia America – about us

Headquartered in Irvine, California, Kia America continues to top quality surveys and is recognized as one of the 100 Best Global Brands. Kia serves as the “Official Automotive Partner” of the NBA and offers a complete range of vehicles sold through a network of more than 750 dealers in the U.S., including cars and SUVs proudly assembled in America.*

For media information, including photography, visit www.kiamedia.com. To receive custom email notifications for press releases the moment they are published, subscribe at www.kiamedia.com/us/en/newsalert.

1 EPA estimates not available at time of release. Targeted/projected all electric range, MPGe, and total range based on manufacturer testing.  Actual all electric range, mileage, and total range will vary with options, driving conditions, driving habits and your vehicle’s condition

2 Comparison based on 2021 and 2022 Plug-in Hybrid SUVs as of August 2021.  Plug-in Hybrid SUV class as defined by Kia segmentation.

3 Comparison based on 2021 and 2022 3-row Plug-in Hybrid SUVs as of August 2021.  3-Row Plug-in Hybrid SUV class as defined by Kia segmentation.

4 No system, no matter how advanced, can compensate for all driver error and/or driving conditions. Always drive safely.

5 No AWD system, no matter how advanced, can compensate for all driver error and/or driving conditions. Always drive safely.

6 These features are not substitutes for safe driving and may not detect all objects surrounding vehicle. Always drive safely and use caution

7 Do not use remote climate control or remote start if vehicle is in an enclosed area (e.g., closed garage) or a partially enclosed area without ventilation. Close all doors leading from adjacent living areas to the vehicle area before executing a remote climate control or remote start command. Remote feature support varies by model, model year and trim.

8 Purchase/lease of certain 2022 and newer Kia vehicles with UVO link includes a complimentary 1-year subscription starting from new vehicle retail sale/lease date as recorded by the dealer. After your complimentary 1-year UVO link subscription expires, continued access to the full suite of UVO link services available on your Kia will require a paid subscription at the then-current subscription rate or your use of certain UVO link features may immediately terminate. Use of UVO is subject to agreement to the UVO Privacy Policy (available at owners.kia.com/us/en/privacy-policy.html) and Terms of Service (available at owners.kia.com/us/en/terms-of-service.html). Complimentary UVO link subscription is transferable to subsequent owner during the original UVO link service term. Only use UVO link when safe to do so.  UVO Link may currently be unavailable for Model Year 2022 and newer vehicles sold or purchased in Massachusetts; please see the Kia Owners Portal for updates on availability. Kia Access with UVO link app is available from the Apple App Store or Google Play Store. Kia America, Inc. reserves the right to change or discontinue UVO link at any time without prior notification or incurring any future obligation. Message and data rates may apply. Cellular and GPS coverage is required to use most features. UVO link features may vary by model, model year, and trim level. Features, specifications, and fees are subject to change. For more on details and limitations, visit www.kia.com or your authorized Kia dealer. Apple and App Store are registered trademarks of Apple Inc. Google and its logos are trademarks of Google LLC.

9 SiriusXM is a trademark of Sirius XM Radio Inc.

10 Charging system only works with select devices. Refer to the vehicle’s Owner’s Manual for warnings and instructions.

11 Bose is a registered trademark of Bose Corporation.

12 Rear Occupant Alert is not a substitute for one’s attention and may not detect all movement within the vehicle. Always check the vehicle interior when exiting the vehicle.

13 Available only with Navigation based infotainment system. 1-year service included. After first year, continued access requires subscription at then-current rate. Go to https://owners.kia.com/us/en/uvo-availability.html for more details on specific available features. Navigation is for information purposes only, and Kia does not make any warranties about the accuracy of the information.

14 Amazon and Google devices are sold separately and require a Wi-Fi internet connection. Amazon, Alexa, and all related logos are trademarks of Amazon.com, Inc. or its affiliates. Google, Google Assistant, and all related logos are trademarks of Google, Inc. Do not use remote climate control or remote start if vehicle is in an enclosed area (e.g., closed garage) or a partially enclosed area without ventilation. Close all doors leading from adjacent living areas to the vehicle area before executing a remote climate control or remote start command. Remote feature support varies by model, model year and trim.

15 Engine Idle Notification and Automatic Engine Shut Off notifications require cellular coverage and a compatible smartphone with the Kia Access with UVO link app. Cellular service rates apply.

16 911 Connect must be enabled on head unit and activates after air bag deployment. Requires cellular coverage.

17 On-demand Find My Car with Surround View Monitor requires cellular coverage and a compatible smartphone with the Kia Access with UVO link app. Cellular service rates apply.

18 Last Mile Navigation requires cellular coverage and a compatible smartphone with the Kia Access with UVO link app. Cellular service rates apply.

19 Driver Attention Warning is not a substitute for safe driving and may not detect all instances of driver fatigue or inattentive driving practices. Failure to pay attention to travel conditions and vehicle operation could result in loss of vehicle control. Always drive safely and use caution.

20 Highway Driving Assist is not a substitute for safe driving, may not detect all objects around the vehicle, and only functions on certain federal highways.  Always drive safely and use caution.

21 Safe Exit Assist is not a substitute for one’s attention and may not detect all objects surrounding the vehicle. Always pay attention to traffic and to the area around your vehicle when exiting the vehicle.

collaborative-robot-market-worth-$10.5-billion-by-2027-–-exclusive-report-by-marketsandmarkets

Collaborative Robot Market worth $10.5 billion by 2027 – Exclusive Report by MarketsandMarkets™

 

According to a research report “Collaborative Robot Market with COVID-19 Impact Analysis, Component, Payload (Up to 5 Kg, 5-10 Kg, and Above 10 Kg), Application (Handling, Processing), Industry (Automotive, Furniture & Equipment), and Region – Global Forecast to 2027”, published by MarketsandMarkets™, the Collaborative Robot Market is projected to grow from  USD 1.2 billion in 2021 and is projected to reach USD 10.5 billion by 2027; it is expected to grow at a CAGR of 43.4% from 2021 to 2027. Owing to COVID-19, the collaborative robot market had to face headwinds for 2019–2020.

Ask for PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=194541294

The high return on investment (ROI) for collaborative robots as compared to traditional industrial robotic system has paved way for their growth in recent years. In addition to this, the benefits derived from adoption of cobots for businesses of all sizes is the key factors driving the collaborative robot market. Many SMEs and large manufacturers that have deployed collaborative robots are benefiting in terms of general competitiveness, increased production, and enhanced quality of their products.

“Cobots with payload capacity up to 5 kg expected to hold the largest share of the market during the forecast period”

Cobots with payload capacity up to 5 kg are expected to hold the largest share of the collaborative robot market during the forecast period. First-time users prefer low payload capacity cobots, which are cheaper and take up less space than robots with higher payload capacity. These cobots are often already fitted with grippers, reducing the hassle of integration and programming for the end user. Another benefit of these cobots is that they are easily re-deployable and take up minimal space when compared to higher payload cobots. Since most of the up to 5 kg payload capacity cobots are very lightweight, they are inherently safe and do not require force sensors, thereby reducing the hardware costs.

“Handling application to dominate collaborative robot market in 2021”

Handling application is expected to hold the largest share of the collaborative robot market in 2021. The handling application includes various sub-types such as material handling, machine tending as well as bin-picking which are currently booming. Handling tasks such as pick and place or palletizing are among the mundane and repetitive in nature for the human workers. Machine tending requires workers to stand for long hours beside a CNC or injection molding machine. Collaborative robots are able to automate a machine tending process during off hours without any supervision, boosting productivity. Besides, handling application has industry-wide usage in varied industries ranging from the automotive, electronics to furniture & equipment because of which is expected to register a fairly large amount of the market share in 2021.

Browse in-depth TOC on “Collaborative Robot Market

197 – Tables
61 – Figures
328 – Pages

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=194541294

“Automotive industry to maintain the largest share of collaborative robot market during the forecast period”

The automotive industry is one of the largest users of collaborative robots. In automotive manufacturing, collaborative robots are used for a variety of applications such as handling, welding, assembling and disassembling, welding, dispensing extensively. Amongst these applications, welding has been one of the first and most popular applications of collaborative robots in the automotive industry. Spray painting automation is another popular application in assembly lines, mainly to protect workers from toxic fumes. Cobots provide consistency in paint application and minimize wastages. Machine tending and material removal are a few of the other applications where cobots are used. As majority of the processes involved in automotive manufacturing and assembly are automated, the automotive industry has to employ collaborative robots on a large scale, which makes it the largest demand generator for the adoption of collaborative robots.

“Collaborative robot market in APAC estimated to grow at the fastest rate during the forecast period”

The collaborative robot market in APAC is expected to grow at the highest rate during the forecast period. With context to the collaborative robot market, the rising costs of labor in the APAC region have caused the SME industries, in particular, to incline towards industrial adoption by integrating collaborative robots in their manufacturing processes to make the operations more efficient and cost-effective. China is at the forefront in the adoption of collaborative robots owing to the increasing demand of automation given the fact that there is a significant growth in its geriatric population in recent years. Besides, China has a significantly strong presence of automotive and electronic industries. These industries are a major demand generator for the adoption of collaborative robots. China is also aiming to become self-sufficient in the manufacture of collaborative robots. Other APAC countries such as Taiwan and Thailand are also not far behind in terms of adopting automation through the integration of cobots to seek a cost advantage, in the wake of rising labour costs. The automotive and electronics industries from the APAC region are the major demand generators for the adoption of collaborative robots.

Key players in the collaborative robot market include Universal Robots (Denmark), FANUC (Japan), ABB (Switzerland), Techman Robot (Taiwan), KUKA (Germany), Doosan Robotics (South Korea), Denso (Japan), YASKAWA (Japan), Precise Automation (US), Rethink Robotics (US), MABI Robotic (Switzerland), FrankaEmika (Germany), Comau (Italy), F&P Robotics (Switzerland), Stäubli (Switzerland), Bosch Rexroth (Germany), Productive Robotics (US). Apart from these, Wyzo (Switzerland), Neura Robotics (Germany), Elephant Robotics (China), ELITE ROBOT (China), Kassow Robots (Denmark), MIP Robotics (France) are among a few emerging companies in the collaborative robot market.

Related Reports:

Industrial Robotics Market with COVID-19 Impact Analysis by Type (Articulated, Collaborative Robots), Component, Payload, Application (Handling, Processing), Industry (Automotive, Food & Beverages), and Region – Global Forecast to 2026

Robot End Effector Market with COVID-19 Impact Analysis, by Type (Electric Grippers, Vacuum Cups, Tool Changers), Robot Type, Application (Handling, Assembly, Processing), Industry (Food & Beverage, E-Commerce), and Region – Global Forecast to 2026

enveric-biosciences-ceo,-david-johnson,-issues-letter-to-shareholders

Enveric Biosciences CEO, David Johnson, Issues Letter to Shareholders

 

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-first biotechnology company developing novel therapeutic drugs to improve the quality of life for cancer patients, Chief Executive Officer, David Johnson, today is issuing an open letter to shareholders.

Dear Fellow Shareholders:

As we approach our annual stockholder meeting on September 14, 2021 and the expected closing of the transaction with MagicMed Industries Inc. (“MagicMed”), we believe we are well-positioned to emerge as a next-generation neuroscience platform. We expect the pending transaction to complement our existing product development activities, which are focused on physical symptoms, with a platform of novel, psychedelics that addresses the large mental health challenges related to CNS indications such as PTSD, anxiety, depression and pain.

We filed our second quarter and first half of 2021 financials last Friday with the SEC, which demonstrates our strong balance sheet of approximately $20 million in cash, no debt and an efficient capital table, affording us the flexibility to be opportunistic about further M&A possibilities and in executing on our current business plan.

We also increased R&D spend during the first half of 2021 and, after the proposed transaction with MagicMed, plan on further investments in mental health initiatives with potential for true disruption in this patient care segment, solidifying our unique position as one of the few NASDAQ-listed mental health companies.

We recognize that the public markets have been difficult for microcap companies in this space for the past several months, and remain committed to executing on our business plan to maximize shareholder value moving forward.

Acquisition of MagicMed

To date, Enveric’s focus has been in the discovery and development of cannabinoid-based therapeutic drugs for patients who suffer from the side effects of cancer therapy. Indications such as Radiation Induced Dermatitis and Chemotherapy Induced Peripheral Neuropathy represent a very large market opportunity and the current standard of care has seen minimal clinical innovation.

Our development activities, however, revealed an even larger opportunity related to a side effect in cancer therapy known as ‘Cancer Related Distress’ (CRD) derived from anxiety, depression and PTSD arising from the diagnosis, treatment protocol or a patient’s concerns about the future. While working to address the physical issues associated with cancer therapy, as a patient-centric company, it became evident that patients also had significant struggles with the mental aspect of their diagnosis. Scientific evidence published by leading academic institutions such as John Hopkins and Yale show the promise of psychedelic molecules as an effective and exciting approach in treating mental health. The FDA’s approval of Janssen’s SPRAVATO® (eskatamine) and its designation of “Breakthrough Therapy” for a Psilocybin and MDMA, further bolsters this published research.

It was with this lens that we started looking for the right partner to enter this space. We have been excited about MagicMed since we first met them. Their library of Intellectual Property for Generation 3molecules, together with their use of Artificial Intelligence, we believe will allow the combined company to address many of the issues not only within our desired cancer indications, but well beyond in this extensive arena of societal mental health problems. In fact, we now believe there is a potential to disrupt the entire market through our IP strategy, which is a very exciting proposition for patients and our shareholders alike.

Dr. Joseph Tucker, current CEO of MagicMed and incoming CEO of Enveric upon the expected closing, and I agree, quite passionately, that mental health is a major global crisis with inadequate current therapies. With a market estimated at more than $250 billion in North America alone, the combined company will be uniquely positioned to bring significant value in the form of efficacious, reliable, life-changing therapies for the patients we seek to serve.

The proposed transaction with MagicMed has now cleared the regulatory approvals and is currently awaiting a shareholder vote of both Enveric and MagicMed shareholders on matters related to the proposed transaction. We expect the proposed transaction to close late in the third quarter or very early in the fourth quarter.

Other key points of progress

Building a World Class Team
To support our growing business, Enveric and MagicMed plan to come together with a very deep and experienced leadership team, while continuously looking for further enhancements. In the second quarter, we announced that Carter Ward had joined the company as our CFO. Carter comes to Enveric with years of Public Company experience in the Life Sciences space, as well as a KPMG pedigree.

To support our growing R&D capabilities and team, we have leased a new discovery facility at the University of Calgary, increasing the efficiency and focus of our R&D activities. In addition, we have just agreed to double our team in Calgary to allow them to accelerate our ability to synthesize and screen more drug candidates.

Finally, we have brought in other new skill sets in Project Management, Clinical Research and a new Scientific Advisory Board Member, Dr. Arash from Cedar Sinai Hospital in Los Angeles

Progressing our Pipeline

  • EV101 has now been given approval for a Phase 1/2 trial in Tel Aviv. We will continue to look at the best pathway forward for this initiative.
  • EV102 continues to make progress in our development program and still shows signs that this could be in the clinic in the first half of 2022.
  • EV104 is a discovery stage program for Pain, creating a Proof of Principal on the Diverse Bio Assets we licensed in Q1 of 2021.

Expansion of Intellectual Property

Enveric Biosciences was granted US patent number 11,090,275 on August 17th. This US patent is the first of three pending patent portfolios directed to cancer treatment using cannabidiol (CBD) owned by Enveric. This patent is part of a larger strategy to build a large and strong Patent portfolio. It is an exciting milestone for the company.

Outlook of Combined Company

The combination of Enveric and MagicMed is expected to uniquely and immediately propel us to emerge as a powerful drug discovery and clinical stage mental health biotechnology company, bringing forward novel therapies to improve the standard of care and unmet medical needs globally.

Our focus is very clear:

  • Continue to progress our pipeline into and through the clinic
  • Close the MagicMed Industries transaction and start to utilize their Psybrary to protect, expand and develop new psychedelic drug candidates, starting with PTSD for cancer
  • Opportunistically look for external development ways to add value to Enveric

I want to thank our shareholders for their support as we approach our September 14th stockholder meeting. As always, we look forward to hearing from you. Please email our investor relations department for more information – [email protected].

Sincerely,

David Johnson,
Chairman and CEO
Enveric Biosciences

thycotic-named-to-inc.-5000-for-ninth-consecutive-year

Thycotic Named to Inc. 5000 for Ninth Consecutive Year

 

ThycoticCentrify, a leading provider of cloud identity security solutions formed by the merger of the privileged access management (PAM) leaders Thycotic and Centrify, today announced that Thycotic has been named to the Inc. 5000 list of fastest growing private companies in America for the ninth consecutive year. Inc. Magazine has recognized Thycotic’s strong business growth and success, ranking the PAM leader at No. 2,432 on their prestigious list for 2021.

Since Thycotic’s ranking on the Inc 5000 list in 2020, the company announced its merger with Centrify to form a leading cloud identity security vendor, a move facilitated and led by TPG Capital. Thycotic and Centrify were both recently recognized as Leaders in the 2021 Gartner Magic Quadrant for Privileged Access Management, and delivered exceptional Q2 results as a combined company. ThycoticCentrify provides one of the most extensive platforms in the privileged identity security market, with PAM-as-a-Service offerings paired with strong identity bridging capabilities and deep experience operating in highly complex environments. ThycoticCentrify expects to debut a new brand and combined solutions portfolio later this year.

“We are honored to be included on the Inc. 5000 list for the ninth year in a row,” said James Legg, President at ThycoticCentrify. “As we move forward as ThycoticCentrify, we remain committed to furthering our development of innovative, cloud-ready identity and privileged access solutions that are accessible and attainable for all – from small businesses to global enterprises.”

The Inc. 5000 list is a distinguished editorial award, celebrating thriving and innovative private companies throughout America. Inc. Magazine announces its annual list every summer, ranking companies by overall revenue growth over a three-year period.

The complete 2021 Inc. 5000 list can be found at https://www.inc.com/inc5000/2021.

optellum-announces-strategic-collaboration-with-the-lung-cancer-initiative-at-johnson-&-johnson,-applying-ai-to-transform-early-lung-cancer-treatment

Optellum Announces Strategic Collaboration With The Lung Cancer Initiative At Johnson & Johnson, Applying AI To Transform Early Lung Cancer Treatment

 

Optellum, a lung-health AI company, has entered a strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson*. Through the collaboration, Optellum will apply its AI-powered clinical decision support platform with the goal of increasing lung cancer survival rates through early intervention and prevention.

Lung cancer is the most common type of cancer and the leading cause of cancer deaths in the world. Approximately 1.8 million people worldwide die from lung cancer each year. The current five-year survival rate is only 20%, primarily due to most patients being diagnosed after the disease has progressed to an advanced stage (Stage III or IV). However, the survival rate for small tumors treated at Stage IA is as high as 90%.

At the core of the collaboration is Optellum’s commercial software, Virtual Nodule Clinic, including an AI-powered digital biomarker based on neural networks and imaging analytics. It identifies and tracks at-risk patients and assigns a Lung Cancer Prediction score to lung nodules; small lesions, frequently detected in chest Computed Tomography (CT) scans, that may or may not be cancerous. The Optellum AI will be used to drive accurate early diagnosis and optimal treatment decisions with the aim of treating patients earlier, potentially at a pre-cancerous stage, increasing survival rates.

The Optellum software achieved US Food and Drug Administration (FDA) clearance in March 2021 and is being implemented in clinical care by leading hospitals initially across the United States, with rollouts in select Asia-Pacific and European markets to follow. The software was extensively validated in multi-center studies led by co-authors of clinical guidelines. In the clinical study underpinning the FDA clearance, all pulmonologists and radiologists in the study showed a statistically significant improvement in their diagnostic accuracy and consistency, and made more optimal clinical management decisions.

Optellum’s vision is to redefine the early intervention of lung cancer by enabling every patient to be diagnosed and treated at the earliest possible stage when the chances of cure are highest. In addition to its lung cancer product portfolio, the company is exploring solutions applying the same technology platform to other deadly diseases of the lungs such as interstitial lung disease and COPD.

“This collaboration is a significant milestone for Optellum,” commented Václav Potěšil, PhD, founder and CEO of Optellum. “It brings us one step closer to Optellum’s vision of redefining early lung cancer treatment by helping every clinician, in every hospital to make the right decisions and provide their patients the best chance to fight back.”

Professor Sam Janes, MD, Head of the Respiratory Research Department at UCL Hospitals, Vice-Chair of the UK National Clinical Reference Group for Lung Cancer and member of the Optellum Medical Advisory Board, commented:

“I believe the next step in lung cancer diagnosis and treatment is seeing the emerging new technologies coming together. AI is key to enabling integration of imaging, clinical, and molecular data—such as liquid biopsies—to diagnose disease even earlier. This convergence of technologies has tremendous potential to help physicians prevent, intercept, and ultimately cure patients with early-stage lung cancer.”